Corindus vascular robotics, inc. (CVRS)
Income statement / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Mar'14Dec'13Mar'13Mar'12
Revenue

-

-

2,842

2,729

2,983

-

896

-

-

Revenue

10,781

9,650

-

-

-

35

-

175

151

Cost of revenue

8,673

9,265

5,042

3,724

4,904

57

2,430

212

123

Gross profit (loss)

2,108

385

-2,200

-995

-1,921

-21

-1,534

-36

-

Operating expenses:
Research and development

8,769

9,517

10,313

10,033

6,607

-

4,793

-

-

Selling, general and administrative

27,300

24,777

19,564

16,143

13,002

-

8,221

-

-

Compensation expense

-

-

-

-

-

10

-

10

9

Consulting fees - related party

-

-

-

-

-

144

-

48

-

General and administrative

-

-

-

-

-

73

-

91

70

Restructuring charge

346

-

-

-

175

-

0

-

-

Total operating expense

36,415

34,294

29,877

26,176

19,784

228

13,014

150

202

Operating loss

-34,307

-33,909

-32,077

-27,171

-21,705

-249

-14,548

-186

-51

Other income (expense)
Interest expense

-

-

-

-

-

17

-

3

0

Warrant revaluation

120

-

-

-

-

-

-

-

-

Interest, net

-884

-208

-

-

-

-

-

-

-

Other, net

82

-6

-

-

-

-

-

-

-

Warrant revaluation

-

-

-

-

2,421

-

-

-

-

Warrant revaluation

-

-

-

-

-

-

-171

-

-

Other, net

-682

-214

-1,001

-1,592

-415

-

28

-

-

Total other income (expense), net

-

-

-

-

-2,836

-

-143

-

-

Other (income) expense, net

-

-

-

-

-

17

-

3

-

Loss before income tax provision

-

-

-

-

-

-267

-

-189

-51

Income tax provision

-

-

-

-

-

0

-

0

0

Net loss

-34,989

-34,123

-33,078

-28,763

-24,541

-267

-14,691

-189

-51

Accretion of beneficial conversion feature of Series A and Series A-1 preferred stock

5,266

-

-

-

-

-

-

-

-

Dividends on preferred stock

2,388

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-42,643

-34,123

-

-

-

-

-

-

-

Net loss per share attributable to common stockholders--basic and diluted (in dollars per share)

-0.22

-0.20

-

-

-

-

-

-

-

Weighted-average common shares used in computing net loss per share attributable to common stockholders--basic and diluted (in shares)

189,619

173,925

-

-

-

-

-

-

-

Net loss per share attributed to common stockholders--basic and diluted (in dollars per share)

-

-

-0.28

-0.25

-0.29

-0.01

-0.20

0.00

0.00

Weighted-average common shares used in computing net loss per share attributable to common stockholders--basic and diluted (in shares)

-

-

119,019

113,254

84,990

52,000

73,360

52,000

-

Net loss

-34,989

-34,123

-33,078

-28,763

-24,541

-267

-14,691

-189

-51

Unrealized gain (loss) on marketable securities

-

-

14

-14

-

-

-

-

-

Comprehensive loss

-34,989

-34,123

-33,064

-28,777

-24,541

-

-14,691

-

-

Weighted average common shares outstanding - basic and diluted

-

-

-

-

-

-

-

-

37,215